FB is up on sympathy with TWTR - both have been violently outperforming the Nasdaq for over a week. This cannot last. They will revert to form and pull back.
just do it with January puts not December... have more possibilities.
I see upper bollie resistance at 50.46 and further resistance at yesterday's high,
also the volumes suggest overdue profit taking and the stochastic is too high.
good news especially if BTD status is given by FDA.
Still they have to get the stock back above 5.50 again
or the street will start losing respect.
and no financing until trial plans are finalized.
this is good news. too bad it's a tweet nobody knows about.
TALK TO US CHIP.
Patrick Sikorski @pharmacreep 4h
@Mykalt45 $gern breakthrough therapy designation
Patrick Sikorski @pharmacreep 5h
$GERN chip told me no financing until trial plans are finalized. Watch for btd in the interim
Chip had NOTHING to do with the development of Imetelstat or the Mayo trial.
His JOB as CEO is to take care of the FINANCIAL PUBLIC STOCK
and he needs to address issues with a FIRM HAND otherwise the stock will
be victimized like it was today. The guy better step up soon and act like a LEADER.
they have about 50 million in cash equivalents. too much being made about a secondary or shelf. any future offering would only be about 50 million or 10 mil more shares which is next to nothing anyway.
i agree with woofs. as of now, Scarlett has only been riding the coattails of Dr Teffari and the doctors who developed imetelstat. He has not performed very well as CEO. I hope there is
a buyout/merger and this co can be run by a more professional executive.